Compare COCH & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCH | UG |
|---|---|---|
| Founded | 1995 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Package Goods/Cosmetics |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 27.7M |
| IPO Year | N/A | N/A |
| Metric | COCH | UG |
|---|---|---|
| Price | $0.67 | $6.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 141.9K | 10.2K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 10.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | $208,000.00 | ★ $10,060,322.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | ★ N/A | $15.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $5.58 |
| 52 Week High | $1.91 | $11.98 |
| Indicator | COCH | UG |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 63.73 |
| Support Level | $0.64 | $6.16 |
| Resistance Level | $0.70 | $6.74 |
| Average True Range (ATR) | 0.04 | 0.14 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 32.11 | 79.35 |
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.